Publication | Closed Access

Adiposity-independent hypoadiponectinemia as a potential marker of insulin resistance and inflammation in schizophrenia patients treated with second generation antipsychotics

Insulin ResistanceMetabolic SyndromeObesityPsychiatryPsychotic DisorderPsychotropic MedicationDiabetesPsychopharmacologySchizophreniaSchizophrenia PatientsSecond Generation AntipsychoticsSocial SciencesBiological PsychiatryMedicinePsychopathology